ESC 365 - Adaptive versus conventional cardiac resynchronization therapy in asian heart failure patients with moderately wide QRS: primary results from the Mid-Q Response randomized trial

EHRA Premium Access

Adaptive versus conventional cardiac resynchronization therapy in asian heart failure patients with moderately wide QRS: primary results from the Mid-Q Response randomized trial

Session: Device therapy 2

Topic: Cardiac Resynchronisation Therapy (CRT)

Speaker: Doctor S. Park (Seoul, KR)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Seung-Jung Park

Samsung Medical Center, Seoul (Korea (Republic of))

0 follower

5 more presentations in this session

Primary prevention ICD implantation in non-ischemic cardiomyopathy patients: a retrospective analysis applying the 2023 Dutch Society of Cardiology Guidelines

Speaker: Mr L. Hopman (Amsterdam, NL)

Predictors of late gadolinium enhancement image quality in patients with cardiac devices

Speaker: Miss F. Amrani (Amsterdam, NL)

Conduction system versus right ventricular pacing for bradycardia treatment; 1 year outcomes of a prospective, randomized trial in patients with advanced AV disease

Speaker: Doctor K. Curila (Prague, CZ)

Accurate machine learning classification of atrial high rate events with automated implementation in remote monitoring

Speaker: Doctor A. Thiyagarajah (Bordeaux, FR)

Use of entrainment and overpacing of atrial tachyarrhythmias through CIED in outpatient clinic setting in locating site and termination of AT. Our experience of feasibility and reliability.

Speaker: Doctor G. Criscione (Leiden, NL)

Access the full session

Device therapy 2

Speakers: Doctor S. Park, Mr L. Hopman, Miss F. Amrani, Doctor K. Curila, Doctor A. Thiyagarajah...

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources